• Necrostatin-1: Innovations in RIP1 Kinase Inhibition and Nec

  2026-07-28

  Explore the advanced scientific applications of Necrostatin-1, a potent RIP1 kinase inhibitor, in dissecting necroptosis and related cell death pathways. This article uniquely bridges emerging insights from ferroptosis research and offers protocol-level guidance for translational researchers.

• Berbamine hydrochloride: Precision Tools for Cancer Research

  2026-07-28

  This article addresses pivotal laboratory challenges in cancer research, focusing on the reproducibility and efficacy of Berbamine hydrochloride (SKU N2471) as a potent NF-κB activity inhibitor. Drawing on validated data and real-world scenarios, it guides biomedical scientists and technicians toward robust assay design and vendor selection for cell viability, proliferation, and cytotoxicity workflows.

• ISRIB (trans-isomer): Transforming ISR Inhibition in Fibrosi

  2026-07-27

  ISRIB (trans-isomer) is redefining how researchers target the integrated stress response (ISR) in hepatic fibrosis and beyond. By selectively inhibiting PERK and antagonizing eIF2α phosphorylation, ISRIB opens new avenues for mechanistic and translational studies, especially in non-canonical ATF4-driven fibrogenic pathways. This article provides strategic insights for deploying ISRIB in advanced ER stress research, bridges the gap between bench and bedside, and highlights forward-looking opportunities in disease modeling and therapeutic innovation.

• Olaparib (AZD2281): Synergistic DNA Repair Disruption in Can

  2026-07-27

  Explore how Olaparib (AZD2281) advances BRCA-associated cancer research by synergistically disrupting DNA repair pathways. This article uniquely analyzes recent findings on G4–STAT1 interactions and combination strategies for tumor radiosensitization.

• SB743921: Precision Targeting of KSP for Cancer Cell Cycle A

  2026-07-26

  Explore SB743921, a potent kinesin spindle protein inhibitor, and its advanced role in dissecting cell cycle arrest in mitosis for cancer research. This article delivers unique assay insights and practical guidance for translational oncology.

• TEAD Family in HCC: Prognostic Roles and Ferroptosis Regulat

  2026-07-25

  This study identifies TEAD2 as a novel prognostic marker in hepatocellular carcinoma (HCC) and reveals its role in ferroptosis regulation. Integrative bioinformatics and experimental approaches highlight how TEAD2 upregulation links to poor patient outcomes and immune infiltration, with implications for targeting ferroptosis in HCC management.

• Phytol as a Versatile RXR Activator: Mechanistic Insights an

  2026-07-24

  Explore the multifaceted role of Phytol in retinoid X receptor signaling and advanced lyotropic assay design. This article offers a deep dive into Phytol's mechanisms and practical workflows that distinguish it from conventional nuclear hormone receptor tools.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-07-24

  The Hoechst 33342/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells by assessing nuclear morphology and membrane integrity. This kit is optimized for research use in apoptosis and necrosis studies but is not intended for diagnostic or clinical workflows. Its dual-staining approach supports clear identification of cell states in fluorescence microscopy assays.

• URB597 (KDS-4103): Precision FAAH Inhibition in Neuroinflamm

  2026-07-23

  Explore the advanced use of URB597 in endocannabinoid signaling modulation and neuroinflammation studies. This article offers unique insights into protocol optimization, translational impact, and the practical implications of FAAH inhibition in pain and affective disorder research.

• SHC-1 Inhibition Modulates CFTR Trafficking in Epithelial Ce

  2026-07-23

  This study dissects how SHC-1 inhibition via the MAPK pathway increases plasma membrane CFTR abundance in epithelial models, revealing cell-specific regulation of CFTR trafficking. The findings inform strategies to modulate CFTR in cystic fibrosis and secretory diarrhea research, while also clarifying methodological considerations for model selection.

• Angiotensin 1/2 (5-7): Workflow Innovations in RAS & COVID-1

  2026-07-22

  Angiotensin 1/2 (5-7) redefines experimental RAS and viral binding assays with unmatched solubility and purity. Harness this peptide for high-fidelity hypertension models or to dissect SARS-CoV-2 interactions, leveraging both APExBIO’s quality and cutting-edge reference data.

• Fenofibrate Activates PPARα-YAP Pathway for Liver Enlargemen

  2026-07-22

  A recent study demonstrates that fenofibrate, a PPARα agonist, induces liver enlargement in both adult and aging mice through activation of the PPARα-YAP signaling pathway. These findings reveal that the hepatic response to fenofibrate is age-independent, offering new mechanistic insight for metabolic and aging research.

• DMXAA (Vadimezan) as a STING-Targeted Vascular Disruptor: Ap

  2026-07-21

  DMXAA (Vadimezan) stands out as a potent vascular disrupting agent and apoptosis inducer, uniquely bridging anti-angiogenic and innate immune activation strategies in cancer biology. This article delivers practical workflows and troubleshooting guidance for leveraging DMXAA in advanced tumor models, with actionable insights from recent nanomedicine innovations.

• Gramine Induces Ferroptosis via CUL3–MTDH Ubiquitination in

  2026-07-21

  This study establishes Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a selective ferroptosis inducer in triple-negative breast cancer (TNBC) through modulation of the CUL3–MTDH ubiquitination axis. The findings highlight a mechanistic pathway for ferroptosis induction and offer important implications for targeted cancer biology research.

• Universal nPEC Method Optimizes Dual-Loaded Liposome Analysi

  2026-07-20

  The reference study introduces a nanoparticle exclusion HPLC (nPEC) method as an effective, accurate, and universally applicable strategy for determining the encapsulation efficiency of dual-loaded liposomes containing both hydrophilic and lipophilic drugs. This innovation addresses longstanding analytical challenges and supports reproducible nanomedicine workflows.

11638 records 1/776 page Next 12345 下5页 Last page